Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-033882)

Filing Details

Accession Number:: 0001127602-13-033882
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-06 13:34:50
Reporting Period:: 2013-12-05

Filing Date:: 2013-12-06
Accepted Time:: 2013-12-06 13:34:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1307505	A Vecheslav Elagin	3471 River Hills Drive Cincinnati OH 45244	Evp, Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-05	4,141	$23.74	50,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	68	Indirect	Held in Meridian Savings & Investment Plan (401K)

Footnotes

Prices range from $23.72 per share to $23.78 per share. The reporting person undertakes to provide full pricing information if requestedby the Securities and Exchange Commission, the issuer or a security holder of the issuer.